Pila Pharma AB - Asset Resilience Ratio

Latest as of September 2023: -7.11%

Pila Pharma AB (PILA) has an Asset Resilience Ratio of -7.11% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr-287.00K

≈ $-30.89K USD Cash + Short-term Investments

Total Assets

Skr4.04 Million

≈ $434.45K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Pila Pharma AB's Asset Resilience Ratio has changed over time. Check PILA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Pila Pharma AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Pila Pharma AB.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr-287.00K	-7.11%
Total Liquid Assets	Skr-287.00K	-7.11%

Asset Resilience Insights

Limited Liquidity: Pila Pharma AB maintains only -7.11% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Pila Pharma AB Industry Peers by Asset Resilience Ratio

Compare Pila Pharma AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Pila Pharma AB (None–None)

The table below shows the annual Asset Resilience Ratio data for Pila Pharma AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Pila Pharma AB

ST:PILA Sweden Biotechnology

Market Cap

$5.83 Million

Skr54.13 Million SEK

Market Cap Rank

#28262 Global

#632 in Sweden

Share Price

Skr1.19

Change (1 day)

-7.06%

52-Week Range

Skr1.10 - Skr3.03

All Time High

Skr12.40